Larvicides Market Overview
larvicide
market reached a value of USD 0.9 billion in 2022 and is expected to experience
steady growth, reaching USD 1.42 billion by 2032. This translates to a compound
annual growth rate (CAGR) of 5.2% during the forecast period (2023-2032).
Competitive
Analysis
Some
of the manufacturers operating in the global larvicides market are Bayer AG
(Germany), BASF SE (Germany), Syngenta (Switzerland), Sumitomo Chemical Co.,
Ltd (Japan), Adama Agan Ltd (Israel), Certis USA LLC (US), Central Garden &
Pet Company (US), Nufarm Limited (Australia), Russell IPM Ltd (UK), Gowan
Company (US), Isagro (Italy), and Arysta LifeScience Corporation (US).
Regional
Analysis
The
larvicides market has been analyzed with respect to five regions, namely,
Asia-Pacific, North America, Europe, Latin America, and the Middle East &
Africa.
The
market in North America dominated the global larvicides market in 2021 on
account of the increasing prevalence of vector-borne diseases in the region.
Increasing
health awareness among citizens coupled with the high spending on healthcare in
Europe is expected to drive product demand in the region during the forecast
period.
The
market in Asia-Pacific is expected to grow substantially due to the increasing
prevalence of vector-borne diseases coupled with the high product demand in the
agriculture industry in the region.
Segment
Analysis
The
global larvicides market has been segmented by type, form, target, application,
and region.
By
type, the
global larvicides
market has
been divided into microbial larvicides, organophosphates, insect growth
regulators, and others. Microbial larvicides are formulated to deliver a
natural toxin to the intended target organisms and are, therefore,
environmentally friendly. Some of the bacteria used as larvicides include
Bacillus sphaericus, Bacillus thuringiensis, and Romanomermis culicivorax.
However, these are effective for a short period of time and are re-introduced
every 15 days. Additionally, fishes such as Gambusia affinis (mosquito fish)
and Poecilia reticulate (common guppy) can be effectively used to control the
mosquito population.
On
the basis of type, the
market has been segregated into liquids, tablets, pellets, granules, and
briquettes. The liquid form of larvicides is highly preferred due to their ease
of application and effectiveness.
Based
on target, the
market has been divided into mosquitoes and flies. The mosquitoes segment
accounted for the majority market share in 2021 due to the high number of
diseases carried by them such as chikungunya, dengue fever, lymphatic
filariasis, Zika, malaria, Lyme disease, West Nile, and Chagas’ disease.
By
application, the
market has been segmented into public health, agriculture, commercial,
residential, and livestock. The public health segment accounted for the largest
market share in 2021. This can be attributed to climatic changes and population
mobility resulting in favorable environments for pest growth.
About US
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients. Our market research studies by products, services,
technologies, applications, end users, and market players for global, regional,
and country level market segments, enable our clients to see more, know more,
and do more, which help to answer all their most important questions. To stay
updated with technology and work process of the industry, MRFR often plans
conducts meet with the industry experts and industrial visits for its research
analyst members.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor New York 10013, United States of America
Sales: +1 628 258 0071 (US) +44 2035 002 764 (UK)
Email: Sales@marketresearchfuture.com
.jpg)
.jpg)
No comments:
Post a Comment